Tomoki Minemura

Toyama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Diffuse Large B-cell Lymphoma with PKM2 and HK2 Expression Presenting with Lactic Acidosis and Hypoglycemia Consistent with the Warburg Effect.

Diffuse Large B-cell Lymphoma with PKM2 and HK2 Expression Presenting with Lactic Acidosis and Hypoglycemia Consistent with the Warburg Effect.

Journal: Internal medicine (Tokyo, Japan)

Published: June 28, 2026

Large B-cell Lymphoma With IRF4 Rearrangement in the Elderly.

Large B-cell Lymphoma With IRF4 Rearrangement in the Elderly.

Journal: Cureus

Published: January 22, 2026

Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial).

Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial).

Journal: Haematologica

Published: January 19, 2026

Antiapoptotic BCL2 family proteins BCL-XL and MCL1 as factors predicting resistance against venetoclax plus azacitidine for patients with newly diagnosed acute myelogenous leukemia.

Antiapoptotic BCL2 family proteins BCL-XL and MCL1 as factors predicting resistance against venetoclax plus azacitidine for patients with newly diagnosed acute myelogenous leukemia.

Journal: PloS one

Published: October 14, 2025

Successful Re-administration and Extended Dosing of Brentuximab Vedotin Monotherapy for Relapsed Anaplastic Large Cell Lymphoma in a Vulnerable Patient.

Successful Re-administration and Extended Dosing of Brentuximab Vedotin Monotherapy for Relapsed Anaplastic Large Cell Lymphoma in a Vulnerable Patient.

Journal: Cureus

Published: May 12, 2025

Complete response using the EZH2 inhibitor tazemetostat against multiple relapsed follicular lymphoma in the leukemic phase.

Complete response using the EZH2 inhibitor tazemetostat against multiple relapsed follicular lymphoma in the leukemic phase.

Journal: International cancer conference journal

Published: June 18, 2024

Cranial hypertrophic pachymeningitis with myelodysplastic syndrome.

Cranial hypertrophic pachymeningitis with myelodysplastic syndrome.

Journal: Heliyon

Published: September 21, 2023

A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL.

A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL.

Journal: International journal of molecular sciences

Published: July 04, 2023

DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.

DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.

Journal: Cells

Published: March 05, 2023

Involvement of activation induced cytidine deaminase in malignant B-cells expressing two distinct M-components as an etiology of biclonal gammopathy.

Involvement of activation induced cytidine deaminase in malignant B-cells expressing two distinct M-components as an etiology of biclonal gammopathy.

Journal: Medicine

Published: January 03, 2023

Massive hyperphosphatemia in clinical tumor lysis syndrome during prophylactic rasburicase use: risk factors and treatment options.

Massive hyperphosphatemia in clinical tumor lysis syndrome during prophylactic rasburicase use: risk factors and treatment options.

Journal: International cancer conference journal

Published: August 18, 2022

Protein-losing Enteropathy Complicated with Primary Intestinal Follicular Lymphoma.

Protein-losing Enteropathy Complicated with Primary Intestinal Follicular Lymphoma.

Journal: Internal medicine (Tokyo, Japan)

Published: November 29, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026